Health Catalyst Inc.
HCAT | NASDAQ
$1.81
+$0.02 (+1.12%)
At close: Sep 21, 2026, 4:00 PM ET
$1.81
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $133.75M
Enterprise Value $48.43M
Beta 1.53
Average Volume 1.31M
Shares Outstanding (Diluted) 73.96M
Shares Change YoY 6.22%
Institutional Ownership 76.91%
Exchange NASDAQ
ISIN US42225T1079
Price Performance
Price Change 1M 16.0%
Price Change 3M 2.8%
Price Change 6M 64.5%
Price Change YTD -20.6%
Price Change 1Y -38.6%
Price Change 3Y -81.5%
Price Change 5Y -96.6%
1M CAGR (ann.) 4.6%
1Y CAGR (ann.) -40.1%
5Y CAGR (ann.) -49.4%
All-Time CAGR -34.9%
Valuation
PE Ratio -0.49
Forward PE 37.30
PEG Ratio 0.01
Forward PEG 0.00
PS Ratio 0.46
Forward PS 0.60
PB Ratio 1.33
P/FCF Ratio 3.71
P/Adj. FCF Ratio 7.26
P/OCF Ratio 4.76
EV/Sales 0.17
EV/EBIT -0.20
EV/EBITDA -0.26
EV/FCF 1.34
Earnings Yield -203.3%
FCF Yield 26.9%
Adj. FCF Yield 13.8%
Financial Health
Net Cash $85.31M
Total Debt $18.13M
Cash & Short-Term Investments $103.44M
Total Assets $358.6M
Current Ratio 2.70
Quick Ratio 2.70
Debt / Equity Ratio 1.69
Debt / EBITDA -0.10
Debt / FCF 0.50
OCF / Debt 2.58
Interest Coverage -2.80
Altman Z-Score -6.55
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 46.4%
Operating Profit Margin -19.7%
EBITDA Margin -64.0%
Net Profit Margin -90.6%
FCF Margin 12.3%
Adj. FCF Margin 6.3%
SBC / Revenue 6.0%
SBC Impact (per share) -48.9%
Returns
Return on Assets -73.8%
Return on Equity -129.7%
Return on Invested Capital -21.1%
Return on Capital Employed -21.6%
Return on Tangible Assets -90.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 0.9%
Revenue CAGR 5Y 6.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -48.9%
EPS CAGR 5Y -2.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 2671.6%
FCF CAGR 5Y 101.8%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 22
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.02
EPS Growth Est (next Q) -133.3%
Revenue Est (next Q) $55.44M
Revenue Growth Est (next Q) -27.4%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $1.77
Price Target Upside -2.2%
Cash Flow
Operating Cash Flow $46.75M
Free Cash Flow $36.04M
Adj. Free Cash Flow $18.42M
FCF Per Share $0.18
OCF Per Share $0.38
OCF/S Ratio 9.7%
Income Statement
Revenue $292.25M
Gross Profit $135.72M
Operating Income $-57.48M
EBITDA $-187.07M
Net Income $-264.82M
EPS (Diluted) -$3.68
Revenue / Employee $243.54K
Profit / Employee $-220.68K
Employees 1,200
Add to Watchlist
Select watchlists to add or remove HCAT